The Original BARK Company Common Stock BARK 深 沪
等待开盘 09-23 09:30:00 美东时间
0.8489
-0.011
-1.23%
华盛通- 最 高0.8587
- 今 开0.8497
- 成交量 25.83万股
- 最 低 0.8414
- 昨 收 0.8595
- 总市值 1.43亿
- 52周最高 2.555
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 0.77
- 委 比 16.28%
- 总股本 1.69亿
- 历史最高 19.54
- 量 比 0.31
- 振 幅 2.01%
- 历史最低 0.701
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BARK Inc Promotes Michael Black to President
The latest announcement is out from BARK Inc Class A ( ($BARK) ). On September ...
09-04 05:47
Insights into Sportsman's Warehouse's Upcoming Earnings
Sportsman's Warehouse (NASDAQ:SPWH) is preparing to release its quarterly earni...
09-04 00:02
Shares of retail companies and consumer stocks are trading lower amid overall market weakness after Walmart reported mixed Q2 financial results. Investor concern about the economy may be weighing down the sector following yesterday's Fed minutes and today's Jobless Claims economic data.
Shares of retail companies and consumer stocks are trading lower amid overall m...
08-22 01:06
Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients
Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for cisplatin therapy.
08-12 22:46
BARK Lowers Q2 Sales Guidance from $123.000M-$126.000M to $102.000M-$105.000M
BARK (NYSE:BARK) lowers Q2 sales outlook from $123.000 million-$126.000 million to $102.000 million-$105.000 million.
08-07 19:53
BARK Q1 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $102.861M Beat $99.633M Estimate
BARK (NYSE:BARK) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly
08-07 19:53
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
NetworkNewsWire Editorial Coverage NEW YORK, Aug. 4, 2025 /PRNewswire/ -- As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that d...
08-04 20:30
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular dystrophy patients.
07-25 23:09
BARK receives non-compliance notice with NYSE listing standards
BARK (NYSE:BARK) said on Friday that the New York Stock Exchange has issued a notice on July 10, 2025, informing the company that it is no longer in compliance with its continued listing standards. Th...
07-12 04:13
